External quality assurance scheme for Haemophilus influenzae 2011
External quality assurance scheme for Haemophilus influenzae 2011
External quality assurance scheme for Haemophilus influenzae 2011
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
TECHNICAL REPORT<br />
<strong>External</strong> <strong>quality</strong> <strong>assurance</strong> <strong>scheme</strong> <strong>for</strong> <strong>Haemophilus</strong> <strong>influenzae</strong><br />
Contents<br />
Abbreviations ................................................................................................................................................ v<br />
Executive summary ........................................................................................................................................ 1<br />
Introduction .................................................................................................................................................. 2<br />
1 Material and methods .................................................................................................................................. 3<br />
1.1 Study design ....................................................................................................................................... 3<br />
1.2 Participants......................................................................................................................................... 3<br />
1.3 Timelines ............................................................................................................................................ 3<br />
1.4 The EQA panel material ....................................................................................................................... 4<br />
1.4.1 Bacterial isolates .......................................................................................................................... 4<br />
1.4.2 Non-culture simulated meningitis samples ...................................................................................... 4<br />
2 Results ....................................................................................................................................................... 5<br />
2.1 Part 1: Characterisation of viable isolates .............................................................................................. 6<br />
2.1.1 Phenotypic species identification .................................................................................................. 10<br />
2.1.2 Phenotypic serotyping ................................................................................................................. 10<br />
2.1.3 Biotyping ................................................................................................................................... 10<br />
2.1.4 Genotypic species identification ................................................................................................... 11<br />
2.1.5 Genotypic capsule typing ............................................................................................................ 12<br />
2.1.6 Other molecular typing ............................................................................................................... 12<br />
2.2 Part 2: Antimicrobial susceptibility testing ............................................................................................ 12<br />
2.2.1 β-lactamase activity testing ......................................................................................................... 12<br />
2.2.2 Antimicrobial susceptibility testing ................................................................................................ 12<br />
2.3 Part 3: Non-culture detection of H. <strong>influenzae</strong> ...................................................................................... 14<br />
2.4 Part 4: Summary comparison of IBD-Labnet H. <strong>influenzae</strong> EQA panels 2009 and <strong>2011</strong> ............................ 15<br />
Overall comments ........................................................................................................................................ 16<br />
Conclusions ................................................................................................................................................. 18<br />
References .................................................................................................................................................. 19<br />
Annex 1. Participating reference laboratories .................................................................................................. 21<br />
Annex 2. Consensus results <strong>for</strong> <strong>Haemophilus</strong> <strong>influenzae</strong> identification, typing and antimicrobial susceptibility testing 23<br />
Annex 3. Example of report generated by UK NEQAS ...................................................................................... 25<br />
iii